Dr. Zheng has been a member of the ERX Board since 2018. She is the President of GP Capital Emerging Industry Co. Ltd., leading over 10 direct overseas investments across US and Europe, most of which are pharmaceutical companies. Before joining GP Capital, Dr. Zheng worked as a physician for nine years and in investment banking for 15 years. She was the former project manager of the investment banking department of Haitong Securities Co., Ltd., assistant general manager of the Shanghai investment bank department of Taiyang Securities Co., Ltd., managing director and deputy general manager of the investment banking department of Qilu Securities Co., Ltd., and the executive deputy general manager and managing director of the investment banking department of Huafu Securities Co., Ltd. Dr. Zheng has led a series of IPO projects, including Chang Dian Technology (the first packaging testing enterprise in China), Da Gang Joint-stock Company, Xin Peng Industry Ltd. (the first professional sheet metal IPO in China), Bao Tong Belt Industry Ltd., NGS Real Estate, Jiangsu Sfere Electric Co. Ltd., among others. She presided over the audit and investment decision-making of more than 10 projects when she took a dual role in the first investment decision-making committee of Qilu Securities Direct Investment Corporation. She received a Bachelor of Clinical Medicine from Fudan University’s School of Medicine, and an MBA from Shanghai University of Finance and Economics.